Incisional breast biopsy device

Information

  • Patent Grant
  • 6551253
  • Patent Number
    6,551,253
  • Date Filed
    Friday, February 2, 2001
    23 years ago
  • Date Issued
    Tuesday, April 22, 2003
    21 years ago
Abstract
A biopsy device is provided which includes a localization needle having a guide wire preloaded into the biopsy device. The device includes a stylet having a blade for transecting and separating tissue. The device further includes a cannula for cutting a core of tissue and a garrote wire mechanism for cutting a transection of tissue transverse to the core cut by the cannula. The garrote wire is activated by a trigger mechanism which is locked out by a lockout feature within the device until the garrote wire has been advanced around the core of tissue cut by the cannula.
Description




BACKGROUND




This invention relates generally to surgical instruments and, more particularly, to a device for percutaneous incisional breast biopsy.




The early diagnosis of breast cancer through the use of mammography is very important for reducing the morbidity associated with breast cancer. Early diagnosis enables a physician to treat the breast cancer at a more manageable stage of development. Mammography is capable of detecting very small abnormalities in breast tissue. However, mammography usually cannot differentiate between malignant and benign lesions in the breast. Definitive determination of the status of a lesion often requires a histological examination of the suspect tissue.




One method for obtaining a tissue sample for histological examination is through a biopsy of part or all of the suspect tissue. There are a number of devices and methods for performing a biopsy of the breast. Generally, the procedure requires first placing a localization needle within or near the lesion. A guide wire contained within the localization needle is then deployed. The guide wire usually includes hooks that anchor one end of the guide wire in breast tissue near the lesion. Then a biopsy device that includes a cannula and a stylet located within the cannula is inserted over the localization needle and guide wire. The device is inserted through a small incision in the breast tissue near the entry point of the localization needle. The stylet bluntly separates breast tissue as the device is inserted over the guide wire toward the lesion. Advancement of the device is stopped once the tip of the stylet is within or near the lesion. Then, the cannula, which has a cutting surface at a leading edge, is advanced over the stylet and into the tissue thereby cutting a core of tissue. The cutting surface is advanced to a point beyond the end of the guide wire. Then, a second cutting surface, typically a wire garrote, is activated to perform a cut transverse to the core and to a longitudinal axis of the cannula creating a tissue sample. Then the needle, guide wire, and device are retracted from the breast with the tissue sample. The tissue sample is then histologically examined to determine whether the suspect tissue is malignant or benign.




The current biopsy devices have a number of disadvantages including that the device, localization needle, and guide wire are not manufactured as a single unit; also the devices generally do not have a means for insuring that the garrote wire is located past the end of the guide wire prior to deployment of the garrote. To determine whether the garrote is located past the end of the guide wire with a typical biopsy device, a radiographic check is required. Finally, the typical blunt stylet requires substantial force to insert and may cause trauma to the healthy tissue as it passes to the biopsy site.




Therefore, it is desirable to provide a biopsy device manufactured as an integrated unit having a localization needle and a guide wire. Additionally, it is desirable to provide a biopsy device having features to insure that the garrote wire is not deployed until it is past the end of the guide wire. It is also desirable to provide a stylet with cutting members to cleanly transect and separate breast tissue and minimize the damage to healthy tissue.




SUMMARY OF THE INVENTION




The present invention overcomes the problems with previous biopsy devices by providing a biopsy device which is manufactured with an integral localization needle and guide wire. In addition, the invention includes structure to insure that the garrote wire is not deployed until the garrote wire is beyond the end of the guide wire. Further, the stylet is provided a blade which transects tissue as the device is inserted to the biopsy site.




According to one aspect of the present invention, the device includes a cannula having a shaft with a cutting surface on one end of the shaft and the other end of the shaft in engagement with a drive assembly. Adjacent to the cutting surface of the cannula is a second cutting mechanism for making a cut transverse to a cut made by the shaft cutting surface. Located within the cannula shaft is a stylet. The stylet has a tip portion with a blade for transecting and separating tissue and a central chamber for permitting a localization needle to pass through the length of the stylet. The localization needle has an interior chamber permitting passage of a guide wire through the length of the localization needle. The device also includes a lock feature for preventing deployment of the second cutting mechanism until it is past the end of the guide wire.




According to a further aspect of the present invention, a method of removing suspect breast tissue with a breast biopsy device includes the steps of inserting a localization needle into tissue, advancing a hooked guide wire out of a distal end of the localization needle to anchor the biopsy device in the tissue in or near a lesion, advancing a stylet and cannula over the localization needle until the stylet is adjacent the lesion, advancing a cannula shaft cutting surface to cut a core of tissue, unlocking a trigger of a garrote when a cutting plane of the garrote has been advanced past a distal end of the guide wire, and moving the trigger to activate the garrote and make a cut transverse to the direction of advancement of the cannula shaft.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a perspective view of a biopsy device designed according to the invention mounted on an instrument holder;





FIG. 2A

is an exploded view of a stylet of the present invention;





FIG. 2B

is a side view of the stylet end.





FIG. 2C

is a side view of the stylet end rotated 90° from the position in FIG.


2


B.





FIG. 3

is a perspective view of the stylet entering a tissue sample.





FIG. 4

is a perspective view of the stylet and a localization needle and a guide wire entering the tissue sample;





FIG. 5

is a perspective view of the localization needle and the guidewire inserted into the tissue sample and the stylet retracted within a cannula of the biopsy device;





FIG. 6

is a perspective view of the cannula cored into the tissue sample;





FIG. 7

is a perspective view of the cannula with a portion of the tissue pulled into the cannula by the guidewire;





FIG. 8

is an exploded view of a cannula assembly;





FIG. 9

is an exploded view of the biopsy device with an upper and lower housing removed;





FIG. 10A

is a top view of the biopsy device with the upper housing removed and the cannula shaft in a retracted position;





FIG. 10B

is a top view of the biopsy device with the upper housing removed and the cannula shaft in an extended position;





FIG. 10C

is a top view of the biopsy device with the upper housing removed and the trigger partially deployed;





FIG. 10D

is a top view of the biopsy device with the upper housing removed showing full deployment of the trigger;





FIG. 10E

is a top view of the biopsy device with the upper housing removed showing resetting of the trigger;





FIG. 10F

is a top view of the biopsy device with the upper housing removed and shown after completion of a transection of the tissue sample;





FIG. 11

is an exploded view of an alternative cutting mechanism housed within the cannula;





FIGS. 12A-12B

are side views of an alternative garrote wire mechanism including an inner and outer sleeve shown prior to and during deployment, respectively;





FIGS. 13A-13B

are side and cross-sectional views, respectively, of an alternative garrote wire mechanism including a first and a second independent sleeve;





FIG. 14

is a cross-sectional view of an alternative garrote wire mechanism including a first and second sleeve interconnected by a spring; and





FIG. 15

is a perspective view of an alternative garrote wire mechanism comprising a wire spool mechanism.











DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT




Referring to the Figures wherein like numerals indicate like or corresponding parts throughout the several view, in

FIG. 1

a biopsy device is shown generally at


10


. The device


10


is shown mounted on an instrument holder


140


. The instrument holder


140


includes a housing


142


and a rotation knob


144


mounted within the housing


142


. A bracket


146


connects the housing


142


to a track


148


. The track


148


can be fixed to a point along a rail (not shown) by a friction cam brake (not shown). The device


10


includes a housing


11


having a trigger slot


25


. A trigger


26


extends through the trigger slot


25


. A stylet retracting knob


56


is mounted adjacent a front end


9


of the housing


11


and connected to a stylet tube


52


(See FIGS.


1


and


2


A). A localization needle


62


passes thought the stylet retracting knob


56


and through the stylet tube


52


. A hub


64


is mounted on a proximal end of the localization needle


62


.




A guide wire


66


is slidably received within the localization needle


62


. A stop


68


is mounted on one end of the guide wire


66


. A cannula


14


extends from a front end


9


of the housing


11


. A stylet


18


is mounted on the stylet tube


52


and the stylet


18


extends beyond the end of the cannula


14


when the stylet tube


52


is extended and the cannula


14


is retracted.




In

FIGS. 2A-2C

the stylet


18


is shown in greater detail. The stylet


18


comprises a first blade


16


and a second blade


17


integrated between two halves of a stylet housing


21


onto an end of the stylet tube


52


. The stylet housing


21


is preferably cone shaped with the first blade


16


and the second blade


17


exiting the cone. The stylet


18


transects, dilates, and separates tissue as the device


10


is inserted toward the biopsy site. In a preferred embodiment a leading edge


27


of the stylet housing


21


forms a forty five degree angle with the center axis


29


of the stylet housing


21


. The leading edge


27


is then radiused at


31


into the body


33


of housing


21


. Body portion


33


is generally parallel to the center axis


29


. The first blade


16


and the second blade


17


are exposed in a curved fashion from an end


31


′ of the stylet housing


21


and extend to the center axis


29


of the stylet housing


21


.




With reference to

FIGS. 3-7

, the biopsy device


10


is shown in various stages of deployment. First an incision


6


is made in the external surface of a breast tissue


5


adjacent a tissue lesion


7


, the localization needle


62


is inserted into the lesion


7


, and the guidewire


66


located within the localization needle


62


is deployed to anchor the biopsy device


10


in the lesion


7


. Preferably, the guidewire


66


consists of a single wire with a barb


67


for marking, stabilizing, and holding the lesion


7


. Alternatively, the guidewire


66


may consist of two or more wires and two or more barbs


67


for increasing the holding ability of the guidewire


66


in various densities of the breast tissue


5


. The cannula


14


and the stylet


18


are then advanced over the localization needle


62


with the stylet


18


and blades


16


,


17


transecting and separating the healthy breast tissue


5


with minimal trauma to the healthy tissue as the cannula


14


is inserted toward the lesion


7


. The cannula


14


is then simultaneously advanced and rotated to core lesion


7


. A cutting ring


70


is mounted within the cannula nose of the cannula


14


to provide the cutting action as the cannula


14


is extended. Once the core of lesion


7


has been cut a garrote wire cutting mechanism, as described below, is deployed to transect the tissue core creating an excised sample of tissue.





FIG. 8

shows an exploded view of the cannula


14


and

FIG. 9

shows an exploded view of the device


10


. A garrote wire


74


having a looped section


75


that acts as a cutting surface is provided within the cannula


14


. A center portion


77


of the garrote wire


74


extends from the looped section


75


into recessed garrote tubes


78


located on a side of the cannula


14


. The garrote wire


74


exits the garrote tubes


78


and then proceeds into an opening


78




a


in the cannula


14


. The garrote wire


74


then proceeds through an opening


94


in shaft


22


and continues through a hole


96


in a spline gear


36


and through a notch


98


in a stop ring


38


. A first end of the garrote wire is attached to a trigger plunger


40


. A second end of garrote wire


74


is attached to the spring plunger


40


. A second end of garrote wire


74


is attached to the spring plunger


48


. In the disclosed embodiment, an end cap


87


covers the end of cannula


14


. The trigger plunger


40


is activated by movement of a trigger body


24


that is connected to trigger


26


and is used to activate the garrote wire


74


and cut the tissue plug in a direction transverse to the direction in which the cannula


14


was advanced. When the trigger


26


is pulled, the trigger body


24


engages the trigger plunger


40


causing trigger plunder


40


to move and pull one side of garrote wire


74


. As plunger


40


moves, it engages and compresses spring


46


against spring plunger


48


. Since spring plunger


48


can move with respect to trigger plunger


40


, the side of the garrote wire


74


attached to spring plunger


48


can move in the opposite direction to the side of the garrote wire


74


attached to trigger plunger


40


. In this way, there is a slight sawing action of the garrote wire


74


.




The trigger


26


is provided with a locking mechanism, comprising a pair of trigger lock ramps


34


and a lock depressor


42


, for preventing deployment of the garrote wire


74


prior to movement of a cutting plane of the garrote wire


74


past an end of the guidewire


66


. The lock ramps


34


have a distal end


200


and a proximal end


210


. The proximal end


210


is attached to the lower housing


58


at attachment points


220


. The distal end


200


of lock ramps


34


is a free end and is adjacent a surface


250


of the trigger body


24


keeping the trigger body


24


from moving in a direction toward the lock ramps


34


. In an undepressed state the distal end


200


is located at a height greater than that of the proximal end


210


relative to the housing


58


. The lock depressor


42


is slidably mounted on a surface


230


of lower housing


58


and is connected to the trigger plunger


40


through a raised portion


240


of the lock depressor.




In application, as the cannula


14


is advanced to cut a core of tissue


5


and lesion


7


the trigger plunger


40


is advanced along the shaft


22


and thereby advances the lock depressor


42


along the lock ramps


34


depressing the distal end


200


of the lock ramps


34


. This process continues until the cannula


14


has been advanced a predetermined distance to a point whereby the cutting plane of the garrote wire


74


contained within the cannula


14


has been advanced beyond the guide wire


66


and is thereby clear to make a cut. At this point, the distal end


200


of the lock ramps


34


are fully depressed by the lock depressor


42


and allow the trigger body


24


to move over the ramps


34


to deploy the garrote wire


74


.




In a preferred embodiment of cannula


14


as shown in

FIG. 8

, the cannula


14


contains a distal disk blade


72


and a proximal disk blade


76


providing cutting surfaces in addition to cutting ring


70


to assist the garrote wire


74


in transecting the lesion


7


. Alternatively, the cannula


14


could contain a plurality of additional blades. In this embodiment the garrote wire


74


exits the cannula


14


through a notch


80


in the proximal disk blade


76


and the looped section


75


of the garrote wire


74


is located between the proximal disk blade


76


and the distal disk blade


72


.




In operation, the garrote wire


74


pulls the lesion


7


against the disk blades


72


and


76


to facilitate cutting of the lesion


7


. Since the garrote is positioned between blades


72


and


76


, the lesion


7


is pulled against the blades


72


and


76


which cuts into the lesion. By pulling the trigger


26


, the garrote wire


74


cuts through one side of the lesion


7


as the blades


72


and


76


cut through the opposite side.




In

FIG. 9

, a drive assembly


82


is shown mounted within the housing


11


. Housing


11


includes an upper housing


12


and a lower housing


58


. The drive assembly


82


includes a cylindrical shaft


22


with a proximal end


88


and a distal end


86


. The distal end


86


of shaft


22


has a larger diameter than the proximal end


88


. A portion of shaft


22


beginning at the proximal end


88


contains a spline


84


for mounting the spline gear


36


. A screw base


90


is formed within the lower housing


58


. A lead screw


50


is mounted to the screw base


90


and extends into an internally threaded portion of the proximal end


88


of the shaft


22


, thereby supporting the proximal end


88


of the shaft


22


. A shaft housing


192


is formed in an end of lower housing


58


and supports the distal end


86


of shaft


22


. A drive gear


32


is mounted within the lower housing


58


and engages the spline gear


36


. In use, the drive gear


32


is driven by rotation of the rotation knob


144


and in turn drive gear


32


rotates the spline gear


36


. Rotation of the spline gear


36


advances the shaft


22


down the lead screw


50


. Movement of the shaft


22


advances and rotates the cannula


14


into the tissue which cuts a core of tissue as the cutting ring


70


rotates and advances. A compression spring


46


is mounted around the shaft


22


and is held at one end by a clip


44


and at another end by a spring plunger


48


. Located between the clip


44


and the spline gear


36


are the stop ring


38


and the trigger plunger


40


. The triggers


26


are connected to the trigger body


24


by a pair of shoulder screws


28


. The trigger body


24


rides on two trigger rods


30


mounted in lower housing


58


and contains an opening


100


which allows the trigger body


24


to engage the trigger plunger


40


. Both the trigger body


24


and the trigger plunger


40


ride over the shaft


22


during activation of the trigger


26


.




In

FIGS. 10A-10B

, the cannula


14


and the lead screw


50


are shown, respectively, before and after coring of the tissue.

FIG. 10A

shows the cannula


14


in a fully retracted position with the lead screw


50


completely inside of the threaded portion of shaft


22


. As the spline gear


36


is rotated the cannula


14


is advanced into the tissue


5


.

FIG. 10B

shows the cannula


14


and the lead screw


50


fully extended. The length of travel of the cannula


14


is limited by the length of the lead screw


50


and the length of the shaft


22


. It is possible in the current invention to have different sizes of biopsy devices


10


including different diameters and lengths of the cannula


14


, corresponding shaft


22


, and the lead screw


50


to provide different diameters and length core samples. In

FIGS. 10A-10B

the trigger


26


is shown in a locked position forward of a pair of trigger lock ramps


34


.




In

FIGS. 10C-10F

, the device


10


is shown in the following stages: partial deployment of the trigger


26


,

FIG. 10C

; full deployment of the trigger


26


,

FIG. 10D

; during return of the trigger


26


,

FIG. 10E

; and after complete transection of the tissue lesion


7


has taken place, FIG.


10


F. To deploy the garrote wire


74


a lock depressor


42


(Shown in

FIG. 9

) depresses the trigger lock ramps


34


allowing the trigger body


24


to ride over and down the ramps


34


. When the triggers


26


are activated, the trigger body


24


slides along the pair of trigger rods


30


. The trigger body


24


interfaces with the trigger plunger


40


pushing the trigger plunger


40


down the shaft


22


, thereby pulling the ends of the garrote wire


74


, which is attached to the trigger plunger


40


and spring plunger


48


, and closing the looped section


75


(not shown) of the garrote wire


74


around the tissue lesion


7


. In

FIG. 10C

, the trigger


26


is only partially deployed and the spring


46


is expanded. In

FIG. 10D

, the trigger


26


is fully deployed and the spring


46


is then compressed. As shown in

FIGS. 10D and 10E

, the spring


46


keeps tension on the spring plunger


48


while the trigger


26


is reset for another pull on the garrote wire


74


. In this embodiment the trigger


26


may be oscillated an unlimited number of times until the garrote wire


74


successfully makes the transection. Multiple oscillations of the trigger


26


enable the actions of the garrote wire


74


to act as a saw on the tissue for cutting difficult tissue. In an alternative embodiment of device


10


, the spring


46


, the stop ring


38


, and the spring plunger


48


, present in the device


10


shown in

FIG. 9

, may be absent from the device


10


allowing for only a one time activation of the trigger


26


and the garrote wire


74


. This is accomplished by attaching both ends of the garrote wire


74


to the trigger plunger


40


.





FIG. 10F

shows the device


10


after a completed tissue transection. After the transection is complete the cannula


14


and the device


10


are retracted from the biopsy site to retrieve the tissue sample present within the cannula


14


.





FIG. 11

shows an alternative embodiment of a cutting mechanism


120


located within the cannula


14


in place of the garrote wire


74


. The cutting mechanism


120


comprises a semi-circular inner blade


114


and a semi-circular outer blade


116


connected by a pair of pivot pins


118


which are supported by a pair of actuation rods


112


. Alternatively the inner blade


114


and the outer blade


116


may be elliptical in shape. The inner blade


114


and the outer blade


116


are supported on a pair of curved cam surfaces


110


that are mounted or molded internally within cannula


14


. In operation, the cutting mechanism


120


is actuated by pulling the actuation rods


112


, thereby forcing the inner blade


114


and the outer blade


116


to follow the cam surface


110


and pivot in an upward direction toward each other. This actuation is made after the cannula


14


is advanced to a desired location. Alternatively, the cutting mechanism


120


may also be used to core a section of tissue


5


and lesion


7


by applying a longitudinal and/or rotational force to the cannula


14


attached to the inner blade


114


and the outer blade


116


in their un-pivoted states.




In

FIGS. 12A-12B

an alternative sleeve mechanism for activating the garrote wire


74


of the biopsy device


10


is shown generally at


100


′. The sleeve mechanism


100


′ comprises a split ring inner sleeve


102


and an outer sleeve


104


mounted around the shaft


22


of the biopsy device


10


. The first end


79


of garrote wire


74


is connected to the inner sleeve


102


and the second end


81


of garrote wire


74


is connected to the outer sleeve


104


. In

FIG. 12A

the mechanism


100


′ is shown in a pre-deployment state with the inner sleeve


102


housed within the outer sleeve


104


and in an expanded state. In use, the garrote wire


74


is activated by pulling the trigger


26


which first pulls down on both the inner sleeve


102


and the outer sleeve


104


simultaneously thereby placing an even force on both the first and second ends,


79


,


81


, of the garrote wire


74


. As the inner and outer sleeves,


102


,


104


, are pulled past a shoulder


106


of the shaft


22


, as shown in

FIG. 12B

the inner sleeve


102


allows the outer sleeve


104


to be pulled over the inner sleeve


102


. The inner sleeve


102


is allowed to contract after it clears shoulder


106


. The inner sleeve


102


is now pulled in an opposite direction against the shoulder


106


. Alternatively, both the inner and outer sleeves


102


,


104


can be replaced by a single sleeve resulting in an even pull on the garrote wire


74


. The need to increase the force on the garrote wire


74


to increase the transection force is determined by the density of the lesion


7


and tissue


5


encountered during the transection. The density of the lesion


7


and the tissue


5


may change as the transection is made through additional layers of tissue, and thus the device as shown in

FIGS. 12A-12B

allows for changes in the force applied to the garrote wire


74


during the transection process.




In

FIGS. 13A-13B

an alternative split sleeve garrote wire mechanism of the biopsy device


10


is shown generally at


128


. As shown in

FIG. 13A

, the split sleeve mechanism


128


comprises a first sleeve half


120


′ and a second sleeve half


122


mounted around the shaft


22


of the biopsy device


10


. As shown in

FIG. 13B

, the first and second sleeve halves


120


′,


122


are mounted on to the shaft


22


in such a way that they are independently movable up and down the shaft


22


, but are not independently rotatable on the shaft


22


. An outside geometry


130


of the shaft


22


and a corresponding inside geometry


132


of the first and second sleeve halves


120


′,


122


prevent the first and second sleeve halves


120


′,


122


from rotating-around the shaft


22


. The geometries


130


,


132


may be any non-circular shape thereby preventing the first and second sleeve halves


120


′,


122


from rotating around the shaft


22


.




In

FIG. 13A

the first end


79


of the garrote wire


74


is connected to the first sleeve half


120


and the second end


81


of the garrote wire


74


is connected to the second sleeve half


122


such that the first and second ends


79


,


81


of the garrote wire


74


move when the first and second sleeve halves


120


,


122


move up and down the shaft


22


. Connected to the first sleeve half


120


is a first lever


126


and connected to the second sleeve half


122


is a second lever


124


for moving the sleeve halves


120


,


122


up and down the shaft


22


. In operation, the first and second levers


126


,


124


may be moved simultaneously pulling equally on the first end


79


and the second end


81


of the garrote wire


74


. The first and second levers


126


,


124


may also be moved independently creating different forces on the first end


79


and the second end


81


of the garrote wire


74


. The first and second lever


126


,


124


may also be alternatively moved together and independently to create an alternating force on the first end


79


and the second end


81


of the garrote wire


74


. The different movements of the first and second levers


126


,


124


may be made at different times during the transection of the tissue by the garrote wire


74


depending on the density of the tissue being cut and the force needed to successfully transect that tissue. Thus, the mechanism provides for oscillatory movement of the garrote wire


74


, creating a sawing action.




In

FIG. 14

an alternative sleeve/spring garrote wire activation mechanism of the biopsy device


10


is shown generally at


150


. The activation mechanism


150


comprises a first sleeve


154


and a second sleeve


152


mounted around shaft


22


. Connected to the first sleeve


154


is the first end


79


of the garrote wire


74


. Connected the second sleeve


152


is the second end


81


of the garrote wire


74


. The first sleeve


154


is connected to the second sleeve


152


by a spring


156


. Alternatively, the spring


156


may consist of a plurality of springs (not shown). In use, the second sleeve


152


is moved down the shaft


22


by a lever mechanism similar to the first and second levers shown in

FIG. 13

, thereby pulling on both the second end


81


of the garrote wire


74


and pulling on the first sleeve


154


through the connection of the spring


156


. The movement on the first sleeve


154


and the corresponding connected first end


81


of the garrote wire


74


is dependent on a spring force constant of the spring


156


. The lower the spring force constant of the spring


156


the less initial movement of the first sleeve


154


takes place due to stretch of the spring


156


. As the spring


156


is stretched to its limit the movement of the first sleeve


154


becomes equal to a rate of movement of the second sleeve


152


. Alternatively, if the spring force constant of the spring


156


is set sufficiently high the first and second sleeves,


154


,


152


may move together initially until the spring force is overcome by the lesion


7


resistance to the cutting action of garrote wire


74


acting on the second sleeve


152


and then the first and second sleeves


154


,


152


may move independently while the spring


156


is stretched and then finally the first and second sleeves


154


,


152


may move together again after the spring


156


has been stretched completely. Alternatively the spring


156


may initially be placed in compression by initially pulling on the first sleeve


154


thereby compressing the spring


156


between the first sleeve


154


and the second sleeve


152


. This alternative creates an initial force less than the spring force on the first end


81


of the garrote wire


74


until the spring


156


compresses and then both the first and second ends


81


,


79


of the garrote wire


74


move together as both the first and second sleeves,


154


,


152


are moved together down the shaft


22


. The activation mechanism


150


creates an oscillating action allowing for differing forces to be applied to the garrote wire


74


during the transection of different density tissue.




In

FIG. 15

an alternative spool mechanism for activating the garrote wire


74


is shown generally at


170


. The mechanism


170


includes a garrote wire feed out spool


174


, a washer


178


, a snap ring


176


, a guide collar


172


, and a take up spool


173


, mounted on the lead screw


50


at the proximal end


88


of the shaft


22


. The first end


79


and a length of the garrote wire


74


(not shown) is coiled around the feed out spool


174


and is released from the feed out spool


174


as the second end


81


of the garrote wire


74


connected to the take up spool


173


is pulled and wrapped around the take up spool


173


when the take up spool


173


is rotated by the lead screw


50


. The take up spool


173


is rotated thereby pulling the garrote wire


74


through the lesion


7


surrounded by the looped section


75


of the garrote wire


74


thereby creating a saw like action on the lesion


7


. The take up spool


173


is rotated until a successful transection of the lesion


7


has been completed.




The invention has been described in an illustrative manner, and it is to be understood that the terminology that has been used is intended to be in the nature of words of description rather than of limitation. Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is, therefore, to be understood that within the scope of the appended claims the invention may be practiced otherwise than as specifically described.



Claims
  • 1. A biopsy device, comprising:cannula having a shaft; a retractable stylet having a tip containing at least one blade and a central passage; a localization needle disposed within the central passage; a drive mechanism for simultaneously rotating said cannula and moving said cannula in a direction parallel to a longitudinal axis of said cannula; a garrote coupled to the cannula and being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger for deploying said garrote and for preventing deployment of said garrote prior to movement of said cannula a predetermined distance; and, a spring mounted around said drive mechanism for applying resistance against said garrote.
  • 2. A biopsy device, comprising:cannula having a shaft and a cutting ring; a retractable stylet having a tip containing at least one blade and a central passage; a localization needle disposed within the central passage; a drive mechanism for simultaneously rotating said cannula and moving said cannula in a direction parallel to a longitudinal axis of said cannula; a garrote coupled to-the cannula adjacent the cutting ring and being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger for deploying said garrote and for preventing deployment of said garrote prior to movement of said cannula a predetermined distance; and, a pair of disk blades mounted to the cannula.
  • 3. A biopsy device, comprising:a cannula having a shaft and a cutting ring; a retractable stylet having a tip containing at least one blade and a central passage; a localization needle disposed within the central passage; a drive mechanism for simultaneously rotating said cannula and moving said cannula in a direction parallel to a longitudinal axis of said cannula; a garrote coupled to the cannula adjacent the cutting ring and being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger for deploying said garrote and for preventing deployment of said garrote prior to movement of said cannula a predetermined distance; and, a distal disk blade and a proximal disk blade, the proximal disk blade containing a notch for receiving said garrote as the garrote exits the cannula to form a cutting surface.
  • 4. The biopsy device, as set forth in claim 3, wherein the trigger includes a locking mechanism having a locked position and an unlocked position, wherein the trigger abuts a plurality of ramps that are depressed by a lock depressor during advancement of said cannula when the locking mechanism is in the locked position.
  • 5. The biopsy device, as set forth in claim 4, wherein the trigger can be retracted to deploy the garrote when the locking mechanism is in the unlocked position.
  • 6. A biopsy device, comprising:a cannula having a shaft; a retractable stylet having a tip containing at least one blade and a central passage; a localization needle disposed within the central passage; a drive mechanism for simultaneously rotating said cannula and moving said cannula in a direction parallel to a longitudinal axis of said cannula; a garrote coupled to the cannula and being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger for deploying said garrote and for preventing deployment of said garrote prior to movement of said cannula a predetermined distance; a localization needle having a guide wire mounted within said needle, wherein the trigger includes a locking mechanism for preventing deployment of the garrote until a cutting plane of the garrote is beyond an end of said guide wire.
  • 7. The biopsy device, as set forth in claim 6, wherein the guide wire includes a barb for anchoring one end of said guide wire in a tissue sample.
  • 8. A biopsy device, comprising:a cannula having a shaft; a retractable stylet having a tip containing at least one blade and a central passage; a localization needle disposed within the central passage; a drive mechanism for simultaneously rotating said cannula and moving said cannula in a direction parallel to a longitudinal axis of said cannula; a garrote coupled to the cannula and being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger for deploying said garrote and for preventing deployment of said garrote prior to movement of said cannula a predetermined distance; a trigger plunger coupled to the trigger, one end of the garrote being connected to the trigger plunger; and a spring plunger coupled to the trigger plunger via a spring, another end of the garrote being connected to the spring plunger.
  • 9. The biopsy device, as set forth in claim 8, wherein the trigger includes a locking mechanism having a locked position and an unlocked position, wherein the trigger abuts a plurality of ramps that are depressed by a lock depressor during advancement of said cannula when the locking mechanism is in the locked position.
  • 10. A biopsy device, comprising:a cannula having a shaft and at least one disk blade mounted within the shaft; a retractable stylet having a tip containing at least one blade and a central passage; a drive mechanism for advancing the cannula in a direction parallel to a longitudinal axis of the cannula; a garrote coupled to the cannula, the garrote and the disk blade being adapted to perform a cut traverse to said longitudinal axis of said cannula; a trigger plunger connected to one end of the garrote; and, a spring plunger coupled to the trigger plunger via a spring, another end of the garrote being connected to the spring plunger.
Priority Claims (1)
Number Date Country Kind
PCT/US98/18172 Sep 1998 US
Parent Case Info

This application is a continuation in part application of U.S. patent application Ser. No. 09/692,928 filed Oct. 20, 2000, now U.S. Pat. No. 6,383,145, which is a Continuation in Part Application of U.S. patent application Ser. No. 09/542,623 filed Apr. 04, 2000, now U.S. Pat. 6,267,732, which was a Continuation Application of patent application Ser. No. 09/151,439 filed Sep. 11, 1998, now U.S. Pat. No. 6,080,113 which claims benefit of U.S. Provisional Patent Application 60/058,691 filed Sep. 12, 1997.

US Referenced Citations (109)
Number Name Date Kind
254154 Preston Feb 1882 A
417797 Van Fleet Dec 1889 A
1568008 Thomas Dec 1925 A
1609456 Boyle Dec 1926 A
1615494 Waring Jan 1927 A
2117278 Ainsworth May 1938 A
2919692 Ackerman Jan 1960 A
3470867 Goldsmith Oct 1969 A
3477423 Griffith Nov 1969 A
3605721 Hallac Sep 1971 A
3628524 Jamshidi Dec 1971 A
3850158 Elias et al. Nov 1974 A
3929123 Jamshidi Dec 1975 A
4010737 Vilaghy et al. Mar 1977 A
4099518 Baylis et al. Jul 1978 A
4174715 Hasson Nov 1979 A
4306570 Matthews Dec 1981 A
4448205 Stenkvist May 1984 A
4461305 Cibley Jul 1984 A
4535773 Yoon Aug 1985 A
4543996 Baron Oct 1985 A
4651752 Fuerst Mar 1987 A
4678459 Onik et al. Jul 1987 A
4776346 Beraha et al. Oct 1988 A
4785826 Ward Nov 1988 A
4817631 Pesch et al. Apr 1989 A
4838280 Haaga Jun 1989 A
4846791 Hattler et al. Jul 1989 A
4850373 Zatloukal et al. Jul 1989 A
4881550 Kothe Nov 1989 A
4926877 Bookwalter May 1990 A
4940061 Teriwilliger et al. Jul 1990 A
4958625 Bates et al. Sep 1990 A
4971067 Bolduc et al. Nov 1990 A
4989614 Dejter, Jr. et al. Feb 1991 A
5009642 Sahi Apr 1991 A
5036860 Leigh et al. Aug 1991 A
5057082 Burchette, Jr. Oct 1991 A
5078142 Siczek et al. Jan 1992 A
5111828 Kornberg et al. May 1992 A
5116353 Green May 1992 A
5127419 Kaldany Jul 1992 A
5133360 Spears Jul 1992 A
5148813 Bucalo Sep 1992 A
5183052 Terwilliger Feb 1993 A
5188118 Teriwilliger Feb 1993 A
5197484 Kornberg et al. Mar 1993 A
5224952 Deniega et al. Jul 1993 A
5240011 Assa Aug 1993 A
5251641 Xavier Oct 1993 A
5257632 Turkel et al. Nov 1993 A
5271380 Riek et al. Dec 1993 A
5271414 Partika et al. Dec 1993 A
5290294 Cox et al. Mar 1994 A
5331972 Wadhwani et al. Jul 1994 A
5352206 Cushieri et al. Oct 1994 A
5353804 Kornberg et al. Oct 1994 A
5364372 Danks et al. Nov 1994 A
5366445 Haber et al. Nov 1994 A
5368607 Freitas Nov 1994 A
5372583 Roberts et al. Dec 1994 A
5372588 Farley et al. Dec 1994 A
5385572 Nobles et al. Jan 1995 A
5394887 Haaga Mar 1995 A
5399167 Deniega Mar 1995 A
5415169 Siczek et al. May 1995 A
5415182 Chin et al. May 1995 A
5419138 Anderson et al. May 1995 A
5423824 Akerfeldt et al. Jun 1995 A
5431151 Riek et al. Jul 1995 A
5449001 Terwilliger Sep 1995 A
5462062 Rubinstein et al. Oct 1995 A
5472426 Bonati et al. Dec 1995 A
5483952 Aranyi Jan 1996 A
5487392 Haaga Jan 1996 A
5488958 Topel et al. Feb 1996 A
5511556 DeSantis Apr 1996 A
5522398 Goldberg et al. Jun 1996 A
5545150 Danks et al. Aug 1996 A
5562696 Nobles et al. Oct 1996 A
5573008 Robinson et al. Nov 1996 A
5607440 Danks et al. Mar 1997 A
5609604 Schwemberger et al. Mar 1997 A
5620456 Sauer et al. Apr 1997 A
5634473 Goldberg et al. Jun 1997 A
5645076 Yoon Jul 1997 A
5645556 Yoon Jul 1997 A
5649547 Ritchart et al. Jul 1997 A
5676156 Yoon Oct 1997 A
5685820 Riek et al. Nov 1997 A
5687739 McPherson et al. Nov 1997 A
5709671 Stephens et al. Jan 1998 A
5718237 Haaga Feb 1998 A
5782775 Milliman et al. Jul 1998 A
5795308 Russin Aug 1998 A
5807276 Russin Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810826 Akerfeldt et al. Sep 1998 A
5817034 Milliman et al. Oct 1998 A
5817061 Goodwin et al. Oct 1998 A
5830219 Bird et al. Nov 1998 A
5857982 Milliman et al. Jan 1999 A
5872775 Saints et al. Feb 1999 A
5879357 Heaton et al. Mar 1999 A
6036657 Milliman et al. Mar 2000 A
6077231 Milliman et al. Jun 2000 A
6080113 Heneveld et al. Jun 2000 A
6080114 Russin Jun 2000 A
6267732 Heneveld et al. Jul 2001 B1
Foreign Referenced Citations (4)
Number Date Country
0761170 Dec 1997 EP
0653191 May 1995 GB
8201988 Jun 1982 WO
9724070 Jul 1997 WO
Provisional Applications (1)
Number Date Country
60/058691 Sep 1997 US
Continuations (1)
Number Date Country
Parent 09/151439 Sep 1998 US
Child 09/542623 US
Continuation in Parts (2)
Number Date Country
Parent 09/692928 Oct 2000 US
Child 09/776444 US
Parent 09/542623 Apr 2000 US
Child 09/692928 US